These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36234788)

  • 1. Discovery of Novel c-Jun N-Terminal Kinase 1 Inhibitors from Natural Products: Integrating Artificial Intelligence with Structure-Based Virtual Screening and Biological Evaluation.
    Yang R; Zhao G; Yan B
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor design against JNK1 through e-pharmacophore modeling docking and molecular dynamics simulations.
    Katari SK; Natarajan P; Swargam S; Kanipakam H; Pasala C; Umamaheswari A
    J Recept Signal Transduct Res; 2016 Dec; 36(6):558-571. PubMed ID: 26906522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-stage virtual screening of natural products against p38α mitogen-activated protein kinase: predictive modeling by machine learning, docking study and molecular dynamics simulation.
    Yang R; Zha X; Gao X; Wang K; Cheng B; Yan B
    Heliyon; 2022 Sep; 8(9):e10495. PubMed ID: 36105464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, and Biological Evaluation of Quercetagetin Analogues as JNK1 Inhibitors.
    Hierold J; Baek S; Rieger R; Lim TG; Zakpur S; Arciniega M; Lee KW; Huber R; Tietze LF
    Chemistry; 2015 Nov; 21(47):16887-94. PubMed ID: 26541354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease.
    Shukla R; Singh TR
    J Biomol Struct Dyn; 2020 Jan; 38(1):248-262. PubMed ID: 30688165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of mitogen-activated protein kinase 7 inhibitors from natural products: Combined virtual screening and dynamic simulation studies.
    Alharbi B; Alnajjar LI; Alhassan HH; Khan S; Jawaid T; Abdullaev BS; Alshammari N; Yadav DK; Adnan M; Shamsi A
    J Mol Recognit; 2024 Jan; 37(1):e3067. PubMed ID: 37956676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
    Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
    J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of natural 15-LOX small molecule inhibitors from Chinese herbal medicine using virtual Screening, biological evaluation and molecular dynamics studies.
    Li Y; Zhang Y; Wu X; Gao Y; Guo J; Tian Y; Lin Z; Wang X
    Bioorg Chem; 2021 Oct; 115():105197. PubMed ID: 34426159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy between machine learning and natural products cheminformatics: Application to the lead discovery of anthraquinone derivatives.
    Moshawih S; Goh HP; Kifli N; Idris AC; Yassin H; Kotra V; Goh KW; Liew KB; Ming LC
    Chem Biol Drug Des; 2022 Aug; 100(2):185-217. PubMed ID: 35490393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).
    Mohammad T; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
    J Biomol Struct Dyn; 2019 Apr; 37(7):1813-1829. PubMed ID: 29683402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A deep learning and docking simulation-based virtual screening strategy enables the rapid identification of HIF-1α pathway activators from a marine natural product database.
    A R N; G K R
    J Biomol Struct Dyn; 2024; 42(2):629-651. PubMed ID: 37038705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel ULK1 inhibitors through machine learning-guided virtual screening and biological evaluation.
    Kong MM; Wei T; Liu B; Xi ZX; Ding JT; Liu X; Li K; Qin TL; Qian ZY; Wu WC; Wu JZ; Li WL
    Future Med Chem; 2024; 16(18):1821-1837. PubMed ID: 39145469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning models to select potential inhibitors of acetylcholinesterase activity from SistematX: a natural products database.
    Herrera-Acevedo C; Perdomo-Madrigal C; Herrera-Acevedo K; Coy-Barrera E; Scotti L; Scotti MT
    Mol Divers; 2021 Aug; 25(3):1553-1568. PubMed ID: 34132933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Phytochemicals Targeting c-Met Kinase Domain using Consensus Docking and Molecular Dynamics Simulation Studies.
    Aliebrahimi S; Montasser Kouhsari S; Ostad SN; Arab SS; Karami L
    Cell Biochem Biophys; 2018 Jun; 76(1-2):135-145. PubMed ID: 28852971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining ligand- and structure-based in silico methods for the identification of natural product-based inhibitors of Akt1.
    Mahajan P; Wadhwa B; Barik MR; Malik F; Nargotra A
    Mol Divers; 2020 Feb; 24(1):45-60. PubMed ID: 30798436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a novel JNK (c-Jun N-terminal kinase) inhibitory peptide.
    Ngoei KR; Catimel B; Church N; Lio DS; Dogovski C; Perugini MA; Watt PM; Cheng HC; Ng DC; Bogoyevitch MA
    Biochem J; 2011 Mar; 434(3):399-413. PubMed ID: 21162712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel artificial intelligence protocol to investigate potential leads for diabetes mellitus.
    Gong JN; Zhao L; Chen G; Chen X; Chen ZD; Chen CY
    Mol Divers; 2021 Aug; 25(3):1375-1393. PubMed ID: 33687591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential extracellular signal-regulated protein kinase 2 inhibitors based on multiple virtual screening strategies.
    Yang R; Zhao G; Zhang L; Xia Y; Yu H; Yan B; Cheng B
    Front Pharmacol; 2022; 13():1077550. PubMed ID: 36467098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential matrix metalloproteinase-2 inhibitors from natural products through advanced machine learning-based cheminformatics approaches.
    Yang R; Zhao G; Cheng B; Yan B
    Mol Divers; 2023 Jun; 27(3):1053-1066. PubMed ID: 35773549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.